Real-time enrollment status for this chemotherapy induced peripheral neuropathy (cipn) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:48 AM UTC
| NCT Number | NCT07142304 |
| Recruiting Status | Recruiting |
| Condition | Chemotherapy Induced Peripheral Neuropathy (CIPN) |
| Phase | Clinical Trial |
| Target Enrollment | 142 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Luminate Medical, Inc. |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 13, 2026: Clinical trial NCT07142304 is currently recruiting participants. This clinical trial study for chemotherapy induced peripheral neuropathy (cipn) is actively seeking new participants at 17 locations across the United States. The study is sponsored by Luminate Medical, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07142304 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07142304 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.